Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rusolovo will build a tin smelting complex in Khabarovsk Krai

3/12/24 ROLO

Drone attacked Lukoil's oil depot

3/12/24 LKOH

ITC reported for 2023 by RAS

3/11/24 WTCM

ICPAO Yandex applied to the Moscow Exchange for listing

3/11/24 YNDX

Shareholders of Rosgosstrakh approved dividends

3/11/24 RGSS

SberMarket launched furniture delivery

3/11/24 SBER

VOX raised ₽9.6 million in investment

3/11/24 OTCI

En+ Group completed the first stage of modernization of the Irkutsk HPP

3/11/24 ENPG

RusHydro started designing Tolmachevskaya HPP-4

3/11/24 HYDR

Henderson sales in February were up 37%

3/11/24 HNFG